Our client has developed proprietary, patent-pending technology for the practical application of cannabinoids in many therapeutic areas. Their growing patent-pending cannabinoid based portfolio encompasses a wide range of medical conditions including anti-aging, dermatitis, cancer, weight loss, and inflammation, within OTC and Rx markets across human and animal healthcare. The challenge for the CEO will be to first develop a timely go-to-market strategy that may include licensing technology to others for commercialization and/or direct product development and commercialization.
May 07, 2021